Roche Holding AG (Roche Holding AG) Days Sales Outstanding

: 68.19 (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

Roche Holding AG's average Accounts Receivable for the six months ended in Dec. 2023 was $12,885 Mil. Roche Holding AG's Revenue for the six months ended in Dec. 2023 was $34,488 Mil. Hence, Roche Holding AG's Days Sales Outstanding for the six months ended in Dec. 2023 was 68.19.

The historical rank and industry rank for Roche Holding AG's Days Sales Outstanding or its related term are showing as below:

RHHBY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 62.17 Med: 64.72 Max: 71.74
Current: 70.15

During the past 13 years, Roche Holding AG's highest Days Sales Outstanding was 71.74. The lowest was 62.17. And the median was 64.72.

RHHBY's Days Sales Outstanding is ranked better than
51.75% of 999 companies
in the Drug Manufacturers industry
Industry Median: 71.93 vs RHHBY: 70.15

Roche Holding AG's Days Sales Outstanding increased from Dec. 2022 (64.34) to Dec. 2023 (68.19).

Roche Holding AG Days Sales Outstanding Historical Data

The historical data trend for Roche Holding AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

61.89

63.48

64.86

65.67

69.11

Roche Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding																66.12	61.50	64.34	67.97	68.19

Competitive Comparison

For the Drug Manufacturers - General subindustry, Roche Holding AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roche Holding AG Days Sales Outstanding Distribution

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's Days Sales Outstanding falls into.

Roche Holding AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Roche Holding AG's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (13013.096	+	13455.134)	/	2 )	/	69890.148	*	365
=	13234.115					/	69890.148	*	365
=	69.11

Roche Holding AG's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (12315.637	+	13455.134)	/	2 )	/	34487.743	*	365 / 2
=	12885.3855					/	34487.743	*	365 / 2
=	68.19

Roche Holding AG (OTCPK:RHHBY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Roche Holding AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Roche Holding AG (Roche Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (OTCPK:RHHBY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

RHHVF:USA RHHBF:USA ROG N:Mexico ROz:UK ROGz:UK 0QOK:UK RHO6:Germany ROG:Switzerland RO:Switzerland

Address

Grenzacherstrasse 124, Basel, CHE, 4070

Website

https://www.roche.com

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.